-
ALSO READ
ERIS Lifesciences standalone net profit declines 9.01% in the September 2018 quarter
ERIS Lifesciences consolidated net profit declines 8.19% in the September 2018 quarter
ERIS Lifesciences consolidated net profit rises 20.52% in the March 2018 quarter
ERIS Lifesciences standalone net profit rises 9.52% in the March 2018 quarter
Volumes jump at ERIS Lifesciences Ltd counter
-
On 06 November 2018
Eris LifeSciences has signed a Share Purchase Agreement with Rakesh Dhuria, a promoter of Kinedex for increasing its ownership and control of the Said subsidiary i.e. Kinedex by way of purchase of 12239 equity shares of face value of Rs 10 each. Kinedex is engaged in marketing and selling pharmaceutical products in India reporting a turnover of Rs 512.29 mn.in FY 2017-18Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU